Calcipotriol topical spray - Lipidor/Cerbios-Pharma

Drug Profile

Calcipotriol topical spray - Lipidor/Cerbios-Pharma

Alternative Names: AKVANO®/calcipotriol

Latest Information Update: 24 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cerbios-Pharma; Lipidor
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Psoriasis

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 24 Feb 2016 Phase-I/II development is ongoing in Sweden
  • 30 Aug 2013 Calcipotriol spray formulation - Lipidor/Cerbios-Pharma is available for late-stage development and commercial licensing as of 30 Aug 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top